INTRAVENOUS VINCRISTINE INFUSION - PHASE-I TRIAL

被引：0
|
作者：
JACKSON, DV
SETHI, VS
SPURR, CL
WILLARD, V
WHITE, DR
RICHARDS, F
STUART, JJ
MUSS, HB
COOPER, MR
HOMESLEY, HD
JOBSON, VW
CASTLE, MC
机构：
来源：
CANCER | 1981年 / 48卷 / 12期
关键词：
D O I：
10.1002/1097-0142(19811215)48:12<2559::AID-CNCR2820481203>3.0.CO;2-6
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：2559 / 2564
页数：6
相关论文
共 50 条
  • [21] PHASE-I TRIAL OF INTRAVENOUS CISPLATIN (DDP) WITH SODIUM THIOSULFATE PROTECTION
    WOLIVER, T
    FELTHOUSE, R
    MARKMAN, M
    PHEIFLE, CE
    HOWELL, SB
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1983, 24 (MAR): : 132 - 132
  • [22] A PHASE-I TRIAL OF BRYOSTATIN 1 IN PATIENTS WITH ADVANCED MALIGNANCY USING A 24-HOUR INTRAVENOUS-INFUSION
    JAYSON, GC
    CROWTHER, D
    PRENDIVILLE, J
    MCGOWN, AT
    SCHEID, C
    STERN, P
    YOUNG, R
    BRENCHLEY, P
    CHANG, J
    OWENS, S
    PETTIT, GR
    BRITISH JOURNAL OF CANCER, 1995, 72 (02) : 461 - 468
  • [23] PHASE-I TRIAL OF RECOMBINANT MACROPHAGE COLONY-STIMULATING FACTOR BY RAPID INTRAVENOUS-INFUSION IN PATIENTS WITH CANCER
    REDMAN, BG
    FLAHERTY, L
    CHOU, TH
    KRAUT, M
    MARTINO, S
    SIMON, M
    VALDIVIESO, M
    GROVES, E
    JOURNAL OF IMMUNOTHERAPY, 1992, 12 (01): : 50 - 54
  • [24] PHASE-I STUDY OF VINCRISTINE AND ESCALATING DOSES OF ETOPOSIDE
    JACKSON, DV
    CRUZ, JM
    ZEKAN, PJ
    CAPONERA, ME
    SPURR, CL
    WHITE, DR
    RICHARDS, F
    MUSS, HB
    INVESTIGATIONAL NEW DRUGS, 1989, 7 (2-3) : 203 - 207
  • [25] PHASE-I AND CLINICAL PHARMACOLOGICAL STUDY OF MERCAPTOPURINE ADMINISTERED AS A PROLONGED INTRAVENOUS-INFUSION
    ZIMM, S
    ETTINGER, LJ
    HOLCENBERG, JS
    KAMEN, BA
    VIETTI, TJ
    BELASCO, J
    COGLIANOSHUTTA, N
    BALIS, F
    LAVI, LE
    COLLINS, JM
    POPLACK, DG
    CANCER RESEARCH, 1985, 45 (04) : 1869 - 1873
  • [26] PHASE-I STUDY OF ADRIAMYCIN (ADR) BY 5 DAY CONTINUOUS INTRAVENOUS-INFUSION
    BOWEN, J
    ROSENTHAL, CJ
    GARDNER, B
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1981, 22 (MAR): : 354 - 354
  • [27] PHASE-I STUDY OF DEOXYCYTIDINE ADMINISTERED AS A 120 HOUR CONTINUOUS INTRAVENOUS-INFUSION
    BHALLA, K
    GRANT, S
    MACLAUGHLIN, W
    COLE, J
    BIRKHOFER, M
    KAPPEL, B
    KRITZ, A
    GRAHAM, G
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1988, 29 : 355 - 355
  • [28] PHASE-I AND PHARMACOKINETIC STUDY OF PACLITAXEL BY 24-HOUR INTRAVENOUS-INFUSION
    TAMURA, T
    SASAKI, Y
    EGUCHI, K
    SHINKAI, T
    OHE, Y
    NISHIO, M
    KUNIKANE, H
    ARIOKA, H
    KARATO, A
    OMATSU, H
    NAKASHIMA, H
    SAIJO, N
    JAPANESE JOURNAL OF CANCER RESEARCH, 1994, 85 (10): : 1057 - 1062
  • [29] PHASE-I TRIAL AND PHARMACOKINETICS OF ACIVICIN ADMINISTERED BY 72-HOUR INFUSION
    EARHART, RH
    KOELLER, JM
    DAVIS, TE
    BORDEN, EC
    MCGOVREN, JP
    DAVIS, HL
    TORMEY, DC
    CANCER TREATMENT REPORTS, 1983, 67 (7-8): : 683 - 692
  • [30] PHASE-I TRIAL OF DIHYDROXYANTHRACENEDIONE
    VANECHO, DA
    WHITACRE, MY
    AISNER, J
    WIERNIK, PH
    CANCER TREATMENT REPORTS, 1981, 65 (9-10): : 831 - 834
12345